# Scorpion Therapeutics, Inc. — Form D

Scorpion Therapeutics, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-16. The offering totals $150.0M, of which $125.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-07-16
- Form: D
- Accession: 0000950123-24-006593
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $150.0M
- Amount sold: $125.7M
- Remaining: $24.3M
- Investors: 38
- Date of first sale: 2024-07-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-518868

## Issuer

- Name: Scorpion Therapeutics, Inc.
- CIK: 0001811858
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1  Winthrop Square, Boston, MA, 02110
- Phone: 781-288-5760

## Officers, directors & promoters (24)

| Name | Role | Location |
| --- | --- | --- |
| Jeffrey Albers | Director | Boston, MA |
| Shelley Chu | Director | Lexington, MA |
| Keith Flaherty | Director | Boston, MA |
| Jean-Francois Formela | Director | Cambridge, MA |
| Adam Friedman | Director | Boston, MA |
| Arjun Goyal | Director | Watertown, MA |
| Oleg Nodelman | Director | San Francisco, CA |
| Saurabh Saha | Director | Boston, MA |
| Otello Stampacchia | Director | Boston, MA |
| Mark Chao | Executive Officer | Boston, MA |
| Andrew Fedder | Executive Officer | Boston, MA |
| Adam Friedman | Executive Officer | Boston, MA |
| Erica Jackson | Executive Officer | Boston, MA |
| Brian Piper | Executive Officer | Boston, MA |
| Darrin Stuart | Executive Officer | Boston, MA |
| Amanda Valentino | Executive Officer | Boston, MA |
| Gary Glick | Director | LONDON, X0 |
| Gary Glick | Executive Officer | LONDON, X0 |
| Jean-Francois Joseph Formela | Director | Boston, MA |
| Arjun Joseph Goyal | Director | Boston, MA |
| Peter Joseph Campisi, Jr. | Executive Officer | Boston, MA |
| Keith Joseph Flaherty | Director | Boston, MA |
| Otello Joseph Stampacchia | Director | Boston, MA |
| Shelley Joseph Chu | Director | Boston, MA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-12-07](https://search.stillhousedata.com/formd/0001811858-20-000003) | D | — | $147.0M |
| [2020-05-19](https://search.stillhousedata.com/formd/0001811858-20-000001) | D | — | $24.7M |

## More

- [CIK 1811858 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1811858&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000950123-24-006593.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.